WT1 mutation-associated nephropathy: a single-center experience
Zhihui Yue1*, Haiyan Wang2*, Hongrong Lin1, Juan Yang3, Ting Liu1, Yulin Liu4, Huamu Chen1, Liangzhong Sun1
1 Children’s Kidney Disease Center, Department of Pediatrics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 2 Department of Pediatrics,
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou,
3 Department of Pediatrics, Liaocheng People’s Hospital, Shandong, and 4 Department of Pediatrics, Boai Hospital, Zhongshan, Guangdong Province, China
DOI 10.5414/CN108948
Abstract
This study explored Wilms’ tumor 1 (WT1) mutations in children with, or suspected of having, steroid-resistant nephrotic syndrome (SRNS), referred to or treated in our hospital in the past 6 years as well as the correlation between genotype and phenotype in WT1 mutation-associated nephropathy in Chinese patients. In total, 76 patients participated in the study. WT1 mutations were identified in 15 patients, 5 of whom harbored splice-site mutations in intron 9. Four of these 5 patients exhibited early onset of nephropathy and rapid deterioration of renal function. Missense mutations were detected in 8 patients, 4 of whom harbored hot-site mutations and had early-onset proteinuria. Of these 4 patients, rapid progression to end-stage renal disease was only observed in 1. Nonsense mutations were identified in 2 patients; both had a large number of immature glomeruli in the kidney cortex. Calcineurin inhibitors (CNI) were administered in 8 patients. Two patients with missense mutations and 1 patient with a nonsense mutation achieved complete remission. Two patients with missense mutations and 2 with splice-site mutations showed an improvement. One patient with a splice-site mutation showed no changes. In conclusion, a high WT1 mutation rate was observed in this group of SRNS patients. Patients with splice-site mutations experienced a rapid disease progression, and patients harboring nonsense mutations showed a prominent glomerular developmental delay. CNI therapy was effective in patients with WT1 missense mutations and nonsense mutations.
*These two authors contributed equally.
Author Details
Authors
Departments
- 1 Children’s Kidney Disease Center, Department of Pediatrics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou,
- 2 Department of Pediatrics,
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou,
- 3 Department of Pediatrics, Liaocheng People’s Hospital, Shandong, and
- 4 Department of Pediatrics, Boai Hospital, Zhongshan, Guangdong Province, China
Address
Professor Liangzhong Sun, MD, PhD
Department of Pediatrics, The First Affiliated Hospital
Sun Yat-Sen University
No. 58, Zhongshan Road II, Guangzhou 510080, China
Email:
sunlzh@
mail.sysu.edu.cn
Citation
Zhihui Yue, Haiyan Wang, Hongrong Lin, Juan Yang, Ting Liu, Yulin Liu, Huamu Chen, Liangzhong Sun.WT1 mutation-associated nephropathy: a single-center experience
. 2017; 87: 245-254. doi: 10.5414/CN108948.